Enigma Diagnostics Announces Patent Licence With Applied Biosystems
Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems.
The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence Applied Biosystems has granted to the method claims of the '907 patent.
This complements Enigma's existing licence under certain patents owned by Applied Biosystems for real-time PCR thermal cyclers.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Gyroscopes lead scientists to unusual state of matter in a disorganized structure
Study reveals new method of preparing imaging agents - Dr. Benjamin Rotstein and collaborators unveil an operationally simple method to prepare carbon isotope-labeled versions of drugs and diagnostics
Leading Platform for the Analysis and Biotechnology Industry analytica China 2012 will open in Shanghai in October
Memory loss not enough to diagnose alzheimer's
Nine-Month Figures for 2011: Dynamic, Profitable Growth at Sartorius - Consolidated sales revenue rises 12.2% to 541.4 million euros
Electrochemical sensor for the uncomplicated detection of "hits" on DNA chips
Frozen: Cutting-edge technology reveals structures within cells
Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents